The Use of Indocyanine Green to Visualize the Thoracic Duct and Evaluate Gastric Conduit Perfusion in Esophagectomy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Surgical Technique and Indocyanine Green
2.3. Data Collection
2.4. Statistical Analysis
3. Results
3.1. Cohort Characteristics
3.2. Thoracic Duct Injury and Chylothorax
3.3. Anastomotic Leak
3.4. Adverse Events
4. Discussion
4.1. Key Findings
4.2. Study Limitations
4.3. Comparison to Existing Literature
4.4. Explanation of Findings
4.5. Study Implications and Next Steps
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Manghelli, J.L.; Ceppa, D.P.; Greenberg, J.W.; Blitzer, D.; Hicks, A.; Rieger, K.M.; Birdas, T.J. Management of anastomotic leaks following esophagectomy: When to intervene? J. Thorac. Dis. 2019, 11, 131–137. [Google Scholar] [CrossRef] [PubMed]
- Raymond, D.P.; Seder, C.W.; Wright, C.D.; Magee, M.J.; Kosinski, A.S.; Cassivi, S.D.; Grogan, E.L.; Blackmon, S.H.; Allen, M.S.; Park, B.J.; et al. Predictors of Major Morbidity or Mortality after Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model. Ann. Thorac. Surg. 2016, 102, 207–214. [Google Scholar] [CrossRef] [PubMed]
- Turkyilmaz, A.; Eroglu, A.; Aydin, Y.; Tekinbas, C.; Erol, M.M.; Karaoglanoglu, N. The management of esophagogastric anastomotic leak after esophagectomy for esophageal carcinoma. Dis. Esophagus 2009, 22, 119–126. [Google Scholar] [CrossRef] [PubMed]
- Biere, S.; Maas, K.; Cuesta, M.; van der Peet, D. Cervical or Thoracic Anastomosis after Esophagectomy for Cancer: A Systematic Review and Meta-Analysis. Dig. Surg. 2011, 28, 29–35. [Google Scholar] [CrossRef] [PubMed]
- AlAnezi, K.; Urschel, J.D. Mortality secondary to esophageal anastomotic leak. Ann. Thorac. Cardiovasc. Surg. 2004, 10, 71–75. [Google Scholar]
- Williams, R.N.; Hall, A.W.; Sutton, C.D.; Ubhi, S.S.; Bowrey, D.J. Management of Esophageal Perforation and Anastomotic Leak by Transluminal Drainage. J. Gastrointest. Surg. 2011, 15, 777–781. [Google Scholar] [CrossRef]
- Weidenhagen, R.; Hartl, W.H.; Gruetzner, K.U.; Eichhorn, M.E.; Spelsberg, F.; Jauch, K.W. Anastomotic Leakage after Esophageal Resection: New Treatment Options by Endoluminal Vacuum Therapy. Ann. Thorac. Surg. 2010, 90, 1674–1681. [Google Scholar] [CrossRef]
- Briel, J.W.; Tamhankar, A.P.; Hagen, J.A.; DeMeester, S.R.; Johansson, J.; Choustoulakis, E.; Prters, J.H.; Bremner, C.G.; DeMeester, T.M. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: Gastric pull-up versus colon interposition. J. Am. Coll. Surg. 2004, 198, 536–542. [Google Scholar] [CrossRef]
- Zehetner, J.; DeMeester, S.R.; Alicuben, E.T.; Oh, D.S.; Lipham, J.C.; Hagen, J.A.; DeMeester, T.R. Intraoperative Assessment of Perfusion of the Gastric Graft and Correlation with Anastomotic Leaks after Esophagectomy. Ann. Surg. 2015, 262, 74–78. [Google Scholar] [CrossRef]
- Karliczek, A.; Harlaar, N.J.; Zeebregts, C.J.; Wiggers, T.; Baas, P.C.; Van Dam, G.M. Surgeons lack predictive accuracy for anastomotic leakage in gastrointestinal surgery. Int. J. Color. Dis. 2009, 24, 569–576. [Google Scholar] [CrossRef]
- Ikeda, Y.; Niimi, M.; Kan, S.; Shatari, T.; Takami, H.; Kodaira, S. Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry. J. Thorac. Cardiovasc. Surg. 2001, 122, 1101–1106. [Google Scholar] [CrossRef] [PubMed]
- Miyazaki, T.; Kuwano, H.; Kato, H.; Yoshikawa, M.; Ojima, H.; Tsukada, K. Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J. Surg. 2002, 26, 1319–1323. [Google Scholar] [CrossRef]
- Miao, L.; Zhang, Y.; Hu, H.; Ma, L.; Shun, Y.; Xiang, J.; Chen, H. Incidence and management of chylothorax after esophagectomy. Thorac. Cancer 2015, 6, 354–358. [Google Scholar] [CrossRef] [PubMed]
- Shah, R.D.; Luketich, J.D.; Schuchert, M.J.; Christie, N.A.; Pennathur, A.; Landreneau, R.J.; Nason, K.S. Postesophagectomy Chylothorax: Incidence, Risk Factors, and Outcomes. Ann. Thorac. Surg. 2012, 93, 897–904. [Google Scholar] [CrossRef] [PubMed]
- Bender, B.; Murthy, V.; Chamberlain, R.S. The changing management of chylothorax in the modern era. Eur. J. Cardio-Thorac. Surg. 2015, 49, 18–24. [Google Scholar] [CrossRef] [PubMed]
- Vecchiato, M.; Martino, A.; Sponza, M.; Uzzau, A.; Ziccarelli, A.; Marchesi, F.; Petri, R. Thoracic duct identification with indocyanine green fluorescence during minimally invasive esophagectomy with patient in prone position. Dis. Esophagus 2020, 33, doaa030. [Google Scholar] [CrossRef]
- Du, Z.-S.; Li, X.-Y.; Luo, H.-S.; Wu, S.-X.; Zheng, C.-P.; Li, Z.-Y.; Fu, J.-H. Preoperative Administration of Olive Oil Reduces Chylothorax after Minimally Invasive Esophagectomy. Ann. Thorac. Surg. 2019, 107, 1540–1543. [Google Scholar] [CrossRef]
- Grischke, E.-M.; Röhm, C.; Hahn, M.; Helms, G.; Brucker, S.; Wallwiener, D. ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial. Geburtshilfe Frauenheilkd. 2015, 75, 935–940. [Google Scholar] [CrossRef]
- Zhang, Y.M.; Shi, R.; Hou, J.C.; Liu, Z.R.; Cui, Z.L.; Li, Y.; Wu, D.; Shi, Y.; Shen, Z.Y. Liver tumor boundaries identified intraoperatively using real-time indocyanine green fluorescence imaging. J. Cancer Res. Clin. Oncol. 2017, 143, 51–58. [Google Scholar] [CrossRef]
- Raabe, A.; Nakaji, P.; Beck, J.; Kim, L.J.; Hsu, F.P.K.; Kamerman, J.D.; Seifert, V.; Spetzler, R.F. Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography during aneurysm surgery. J. Neurosurg. 2005, 103, 982–989. [Google Scholar] [CrossRef]
- Slooter, M.D.; Eshuis, W.J.; Cuesta, M.A.; Gisbertz, S.S.; Henegouwen, M.I.V.B. Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: A systematic review and meta-analysis. J. Thorac. Dis. 2019, 11, S755–S765. [Google Scholar] [CrossRef] [PubMed]
- Ashitate, Y.; Tanaka, E.; Stockdale, A.; Choi, H.S.; Frangioni, J.V. Near-infrared fluorescence imaging of thoracic duct anatomy and function in open surgery and video-assisted thoracic surgery. J. Thorac. Cardiovasc. Surg. 2011, 142, 31–38.e2. [Google Scholar] [CrossRef] [PubMed]
- Yang, F.; Zhou, J.; Li, H.; Yang, F.; Xiao, R.; Chi, C.; Tian, J.; Wang, J. Near-infrared fluorescence-guided thoracoscopic surgical intervention for postoperative chylothorax. Interact. Cardiovasc. Thorac. Surg. 2018, 26, 171–175. [Google Scholar] [CrossRef] [PubMed]
- Londero, F.; Grossi, W.; Vecchiato, M.; Martino, A.; Ziccarelli, A.; Petri, R.; Morelli, A. Fluorescence-Guided Identification of the Thoracic Duct by VATS for Treatment of Postoperative Chylothorax: A Short Case Series. Front. Surg. 2022, 9, 912351. [Google Scholar] [CrossRef] [PubMed]
- Kato, M.; Nomura, K.; Ko, Y.; Kinami, H.; Tanami, Y.; Watanabe, S.; Watanabe, A.; Utsunomiya, H.; Fujisawa, K. The use of indocyanine green lymphography for the treatment of postoperative chylothorax with lipiodol lymphangiography in a 2-year-old child. J. Pediatr. Surg. Case Rep. 2017, 23, 46–49. [Google Scholar] [CrossRef]
- Barnes, T.G.; MacGregor, T.; Sgromo, B.; Maynard, N.D.; Gillies, R.S. Near infra-red fluorescence identification of the thoracic duct to prevent chyle leaks during oesophagectomy. Surg. Endosc. 2022, 36, 5319–5325. [Google Scholar] [CrossRef]
- Barbato, G.; Cammelli, F.; Braccini, G.; Staderini, F.; Cianchi, F.; Coratti, F. Fluorescent lymphography for thoracic duct identification: Initial experience of a simplified and feasible ICG administration. Int. J. Med. Robot. 2022, 18, e2380. [Google Scholar] [CrossRef]
- Varshney, V.K.; Nayar, R.; Soni, S.C.; Selvakumar, B.; Garg, P.K.; Varshney, P.; Khera, P.S. Intra-Nodal Indocyanine Green Injection to Delineate Thoracic Duct During Minimally Invasive Esophagectomy. J. Gastrointest. Surg. 2022, 26, 1559–1565. [Google Scholar] [CrossRef]
- Tokumaru, S.; Kitazawa, M.; Nakamura, S.; Koyama, M.; Soejima, Y. Intraoperative visualization of morphological patterns of the thoracic duct by subcutaneous inguinal injection of indocyanine green in esophagectomy for esophageal cancer. Ann. Gastroenterol. Surg. 2022, 6, 873–879. [Google Scholar] [CrossRef]
- Seely, A.J.; Ivanovic, J.; Threader, J.; Al-Hussaini, A.; Al-Shehab, D.; Ramsay, T.; Gilbert, S.; Maziak, D.E.; Shamji, F.M.; Sundaresan, R.S. Systematic Classification of Morbidity and Mortality after Thoracic Surgery. Ann. Thorac. Surg. 2010, 90, 936–942. [Google Scholar] [CrossRef]
- Koyanagi, K.; Ozawa, S.; Ninomiya, Y.; Yarabe, K.; Higuchi, T.; Yamamoto, M.; Kanamori, K.; Tajima, K. Indocyanine green fluorescence imaging for evaluating blood flow in the reconstructed conduit after esophageal cancer surgery. Surg. Today 2022, 52, 369–376. [Google Scholar] [CrossRef] [PubMed]
- Ladak, F.; Dang, J.T.; Switzer, N.; Mocanu, V.; Tian, C.; Birch, D.; Turner, S.R.; Karmali, S. Indocyanine green for the prevention of anastomotic leaks following esophagectomy: A meta-analysis. Surg. Endosc. 2018, 33, 384–394. [Google Scholar] [CrossRef]
- Van Daele, E.; Van Nieuwenhove, Y.; Ceelen, W.; Vanhove, C.; Braeckman, B.P.; Hoorens, A.; Van Limmen, J.; Varin, O.; Van de Putte, D.; Willaert, W.; et al. Near-infrared fluorescence guided esophageal reconstructive surgery: A systematic review. World J. Gastrointest. Oncol. 2019, 11, 250–263. [Google Scholar] [CrossRef] [PubMed]
- Casas, M.A.; Angeramo, C.A.; Harriott, C.B.; Dreifuss, N.H.; Schlottmann, F. Indocyanine green (ICG) fluorescence imaging for prevention of anastomotic leak in totally minimally invasive Ivor Lewis esophagectomy: A systematic review and meta-analysis. Dis. Esophagus 2021, 35, doab056. [Google Scholar] [CrossRef] [PubMed]
- Gooszen, J.A.H.; Goense, L.; Gisbertz, S.S.; Ruurda, J.P.; van Hillegersberg, R.; Henegouwen, M.I.V.B. Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer. Br. J. Surg. 2018, 105, 552–560. [Google Scholar] [CrossRef]
- Bailey, S.H.; Bull, D.A.; Harpole, D.H.; Rentz, J.J.; Neumayer, L.A.; Pappas, T.N.; Daley, J.; Henderson, W.G.; Krasnicka, B.; Khuri, S.F. Outcomes after esophagectomy: A ten-year prospective cohort. Ann. Thorac. Surg. 2003, 75, 217–222. [Google Scholar] [CrossRef]
- Shen, K.R.; Harrison-Phipps, K.M.; Cassivi, S.D.; Wigle, D.; Nichols, F.C.; Allen, M.S.; Wood, C.M.; Deschamps, C. Esophagectomy after anti-reflux surgery. J. Thorac. Cardiovasc. Surg. 2010, 139, 969–975. [Google Scholar] [CrossRef]
Characteristic | ICG for TD and GCP (n = 12) | ICG for GCP Only (n = 11) | No ICG (n = 82) | p Value |
---|---|---|---|---|
Age, y, median (IQR) | 74 (66–76) | 66 (59–72) | 67 (63–74) | 0.219 |
Sex, M:F | 2:1 | 2.7:1 | 3.1:1 | 0.797 |
BMI, kg/m2, median (IQR) | 26.7 (25.2–28.4) | 26.2 (24.2–28.8) | 24.8 (22.1–28.0) | 0.645 |
CCI, median (IQR) | 5 (5–6) | 4 (3–5) | 5 (4–6) | 0.150 |
Previous surgery, n (%) | ||||
Thoracic | 1 (8.3) | -- | 3 (3.7) | 0.574 |
Abdominal | 4 (33.3) | 4 (36.4) | 22 (26.8) | 0.747 |
Smoking history, n (%) | ||||
Current | 2 (16.7) | -- | 15 (18.3) | 0.302 |
Former | 8 (66.7) | 6 (54.4) | 53 (64.6) | 0.788 |
Never smoked | 2 (16.7) | 5 (45.5) | 14 (17.1) | 0.083 |
Characteristic | ICG for TD and GCP (n = 12) | ICG for GCP Only (n = 11) | No ICG (n = 82) | p Value |
---|---|---|---|---|
Tumor type †, n (%) | ||||
Adenocarcinoma | 10 (83.3) | 9 (81.8) | 65 (79.3) | 0.935 |
SCC | 2 (16.7) | 2 (18.2) | 17 (20.7) | 0.935 |
Clinical T stage ‡, n (%) | ||||
T1 | -- | -- | 2 (2.4) | 1.000 |
T2 | 1 (8.3) | -- | 10 (12.2) | 0.502 |
T3 | 10 (83.3) | 9 (81.8) | 58 (70.1) | 0.521 |
T4 | -- | -- | 2 (2.4) | 0.751 |
Unknown | 1 (8.3) | 2 (18.2) | 10 (12.2) | 0.251 |
Clinical N stage ‡, n (%) | ||||
N0 | 6 (50.0) | 3 (27.3) | 32 (39.0) | 0.802 |
N+ | 6 (50.0) | 6 (54.5) | 46 (56.1) | 0.841 |
Unknown | -- | 2 (18.2) | 4 (4.9) | 0.135 |
Location, n (%) | ||||
Upper | -- | -- | 1 (1.2) | 0.868 |
Middle | 4 (33.3) | 2 (18.2) | 10 (12.2) | 0.157 |
Lower | 2 (16.7) | 0 | 13 (15.9) | 0.358 |
GEJ (Siewert 1 and 2) | 6 (50.0) | 9 (81.8) | 58 (70.7) | 0.223 |
Neoadjuvant therapy, n (%) | ||||
CROSS | 11 (91.7) | 8 (72.7) | 75 (91.5) | 0.157 |
FLOT chemotherapy | 1 (8.3) | 2 (18.2) | 7 (8.5) | 0.585 |
Radiation | 0 | 1 (9.1) | 0 | 0.013 |
Surgical approach, n (%) | ||||
MIE | 7 (58.3) | 5 (45.5) | 33 (40.2) | 0.489 |
Three-field | 2 (16.7) | 5 (45.5) | 8 (9.8) | 0.006 |
Open | 2 (16.7) | 1 (9.1) | 32 (39.0) | 0.061 |
Hybrid | 1 (8.3) | -- | 9 (11.0) | 0.502 |
Conversion §, n (%) | 1 (8.3) | 1 (9.1) | 9 (11.0) | 0.779 |
Open | 1 (8.3) | -- | 6 (7.3) | 0.378 |
Three-field | -- | 1 (9.1) | 2 (2.4) | 0.639 |
Hybrid | -- | -- | 1 (1.2) | 0.868 |
Variable | ICG for TD and GCP (n = 12) | ICG for GCP Only (n = 11) | No ICG (n = 82) | p Value |
---|---|---|---|---|
ICG injection site, n (%) | ||||
Small bowel mesentery | 9 (75.0) | -- | -- | <0.001 |
Inguinal lymph nodes | 2 (16.7) | -- | -- | 0.020 |
Web space of feet | 1 (8.3) | -- | -- | 1.000 |
TD visualized via ICG, n (%) | 6 (50.0) | -- | -- | 1.000 |
Intraoperative TD injury, n (%) | -- | -- | 1 (1.2) | 0.867 |
Chylothorax †, n (%) | 1 (8.3) | 1 (9.1) | 10 (12.2) | 0.873 |
Minor Grades | 0.437 | |||
I | -- | -- | 1 (1.2) | |
II | 1 (8.3) | -- | 1 (1.2) | |
Major Grades | 0.532 | |||
IIIa | -- | -- | 4 (4.9) | |
IIIb | -- | 1 (9.1) | 4 (4.9) | |
IVa | -- | -- | -- | |
IVb | -- | -- | -- | |
V | -- | -- | -- |
Outcome | ICG for GCP (n = 23) | No ICG (n = 82) | p Value |
---|---|---|---|
Positive leak test, n (%) | 1 (4.3) | 2 (2.4) | |
Anastomotic leak †, n (%) | 2 (8.7) | 10 (12.2) | 0.409 |
Minor Grades | 0.869 | ||
I | -- | 1 (1.2) | |
II | -- | -- | |
Major Grades | 0.410 | ||
IIIa | 2 (8.7) | 7 (8.5) | |
IIIb | -- | 1 (1.2) | |
IVa | -- | -- | |
IVb | -- | 1 (1.2) | |
V | -- | -- |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Aw, K.; Al Rawahi, A.; Lau, R.; Abdul, S.A.; Anstee, C.; Gilbert, S.; Jones, D.; Seely, A.J.E.; Sundaresan, R.S.; Villeneuve, P.J.; et al. The Use of Indocyanine Green to Visualize the Thoracic Duct and Evaluate Gastric Conduit Perfusion in Esophagectomy. Surgeries 2023, 4, 579-589. https://doi.org/10.3390/surgeries4040056
Aw K, Al Rawahi A, Lau R, Abdul SA, Anstee C, Gilbert S, Jones D, Seely AJE, Sundaresan RS, Villeneuve PJ, et al. The Use of Indocyanine Green to Visualize the Thoracic Duct and Evaluate Gastric Conduit Perfusion in Esophagectomy. Surgeries. 2023; 4(4):579-589. https://doi.org/10.3390/surgeries4040056
Chicago/Turabian StyleAw, Katherine, Aziza Al Rawahi, Rebecca Lau, Sami Aftab Abdul, Caitlin Anstee, Sebastien Gilbert, Daniel Jones, Andrew J. E. Seely, Ramanadhan Sudhir Sundaresan, Patrick James Villeneuve, and et al. 2023. "The Use of Indocyanine Green to Visualize the Thoracic Duct and Evaluate Gastric Conduit Perfusion in Esophagectomy" Surgeries 4, no. 4: 579-589. https://doi.org/10.3390/surgeries4040056